CMC(CMC)
Search documents
CMC Awarded on TIME's America's Best Mid-Size Companies 2024 List
Prnewswire· 2024-08-22 20:48
IRVING, Texas, Aug. 22, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) has earned recognition on TIME's inaugural list of America's Best Mid-Size Companies 2024. This prestigious award is presented by TIME and Statista Inc., the leading statistics portal and industry ranking provider. America's Best Mid-Size Companies 2024 were identified based on employee satisfaction, revenue growth and sustainability transparency for companies that operate in the United States and generated at least $100M in ...
3 Steel Producer Stocks to Watch Amid Industry Challenges
ZACKS· 2024-08-09 14:55
The Zacks Steel Producers industry is buffeted by significant challenges as steel prices have experienced a sharp decline in the United States and globally this year. Soft demand in China amid economic slowdown is also a concern. However, improved demand in the automotive space and a resilient non-residential construction market augur well for the industry. Players from the space like POSCO Holdings Inc. (PKX) , ArcelorMittal S.A. (MT) and Commercial Metals Company (CMC) are worth a look despite near-term h ...
CMC Announces Executive and Board Leadership Changes
Prnewswire· 2024-08-02 11:30
Barbara R. Smith to Retire as Executive Chairman Robert S. Wetherbee Appointed Chairman of the Board of Directors Vicki Avril-Groves to Retire from the Board of Directors Tandra Perkins Appointed to the Board of Directors IRVING, Texas, Aug. 2, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") today announced that Barbara R. Smith, the Executive Chairman of the Company's Board of Directors (the "Board"), will retire from such position and from the Board, effective August 31 ...
Yen-gold correlation is back, and rising JPY could boost gold prices as rates fall – CMC Markets' Oldenburger
KITCO· 2024-07-19 15:01
Ernest Hoffman Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not acc ...
Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation
GlobeNewswire News Room· 2024-07-18 21:00
HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the appointment of Dr. Srini Tenjarla as the new Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Formulation. Dr. Tenjarla brings over 20 years of extensive experience in drug development to Serina. "We are thrilled to welcome Dr. Tenjarla to our team," s ...
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
GlobeNewswire News Room· 2024-07-18 12:25
Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. Resyca is a joint venture ...
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial
Prnewswire· 2024-06-26 12:00
NEW YORK, June 26, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced it has reached alignment with the U.S. Food and Drug Administration (FDA) on the Chemistry, Manufacturing, and Controls (CMC) aspects of Brainstorm's Phase 3b clinical trial for NurOwn®, its investigational therapy for amyotrophic lateral sclerosis (ALS). "This in-person Type C meeting with the FDA was an important step ...
CMC(CMC) - 2024 Q3 - Quarterly Report
2024-06-25 14:41
NOTE 8. DERIVATIVES The decrease in fair value of the Company's commodity derivatives reported within other noncurrent assets is primarily due to the decrease in the value of a significant input used to measure the fair value of the Company's Level 3 commodity derivatives at May 31, 2024 as compared to August 31, 2023. See Note 9, Fair Value, for further discussion of the measurement of the fair value of the Company's Level 3 commodity derivatives. | --- | --- | --- | --- | --- | --- | --- | --- | |-------- ...
美国五金公司
工商银行· 2024-06-23 11:48
Hello and welcome, everyone, to the third quarter fiscal 2024 earnings call for CMC. Joining me on today's call are Peter Matt, CMC's President and Chief Executive Officer, and Paul Lawrence, Senior Vice President and Chief Financial Officer. Today's materials, including the press release and supplemental slides that accompany this call, can be found on CMC's Investor Relations website. Today's call is being recorded. After the company's remarks, we will have a question and answer session, and we will have ...
美国五金公司[C.N]2024年第三季度业绩交流会
工商银行· 2024-06-21 16:01
Hello and welcome, everyone, to the third quarter fiscal 2024 earnings call for CMC. Joining me on today's call are Peter Matt, CMC's President and Chief Executive Officer, and Paul Lawrence, Senior Vice President and Chief Financial Officer. Today's materials, including the press release and supplemental slides that accompany this call, can be found on CMC's Investor Relations website. Today's call is being recorded. After the company's remarks, we will have a question and answer session, and we will have ...